Development of nano-tricalcium phosphate/polycaprolactone/platelet-rich plasma biocomposite for bone defect regeneration

Volume: 13, Issue: 9, Pages: 7160 - 7169
Published: Sep 1, 2020
Abstract
Nano-tricalcium phosphate (n-TCP) is an osteoconductive substance which, like polycaprolactone (PCL), has been used for clinical purposes for many years; It has now been licensed for a range of products for clinical and medication distribution. This research aimed to examine the effects of platelet-rich plasma on mesenchymal stem cell proliferation and osteogenic differentiation. Thus, we decided to examine the in vitro and in vivo actions of...
Paper Details
Title
Development of nano-tricalcium phosphate/polycaprolactone/platelet-rich plasma biocomposite for bone defect regeneration
Published Date
Sep 1, 2020
Volume
13
Issue
9
Pages
7160 - 7169
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.